Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas. more
Time Frame | CLB | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4% | 1.05% | -0.42% |
1-Month Return | -7.98% | -2.06% | -2.2% |
3-Month Return | -5.66% | -4.17% | 2.38% |
6-Month Return | -13.83% | -1.09% | 5.1% |
1-Year Return | 11.8% | 8.39% | 23.79% |
3-Year Return | -32.05% | 44.55% | 26.66% |
5-Year Return | -55.26% | 47.78% | 81.16% |
10-Year Return | -82.68% | 19.19% | 191.72% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 668.21M | 487.27M | 470.25M | 489.74M | 509.79M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":72.92,"profit":true},{"date":"2021-12-31","value":70.37,"profit":true},{"date":"2022-12-31","value":73.29,"profit":true},{"date":"2023-12-31","value":76.29,"profit":true}] |
Cost of Revenue | 518.18M | 395.63M | 386.41M | 410.82M | 415.74M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":76.35,"profit":true},{"date":"2021-12-31","value":74.57,"profit":true},{"date":"2022-12-31","value":79.28,"profit":true},{"date":"2023-12-31","value":80.23,"profit":true}] |
Gross Profit | 150.03M | 91.63M | 83.84M | 78.92M | 94.05M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":61.08,"profit":true},{"date":"2021-12-31","value":55.88,"profit":true},{"date":"2022-12-31","value":52.6,"profit":true},{"date":"2023-12-31","value":62.69,"profit":true}] |
Gross Margin | 22.45% | 18.81% | 17.83% | 16.11% | 18.45% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":83.76,"profit":true},{"date":"2021-12-31","value":79.41,"profit":true},{"date":"2022-12-31","value":71.77,"profit":true},{"date":"2023-12-31","value":82.17,"profit":true}] |
Operating Expenses | 48.02M | 34.03M | 44.17M | 37.40M | 39.41M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":70.87,"profit":true},{"date":"2021-12-31","value":91.98,"profit":true},{"date":"2022-12-31","value":77.87,"profit":true},{"date":"2023-12-31","value":82.06,"profit":true}] |
Operating Income | 96.68M | 55.77M | 45.26M | 41.52M | 54.64M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":57.69,"profit":true},{"date":"2021-12-31","value":46.81,"profit":true},{"date":"2022-12-31","value":42.95,"profit":true},{"date":"2023-12-31","value":56.51,"profit":true}] |
Total Non-Operating Income/Expense | (29.38M) | (28.74M) | (18.30M) | (23.14M) | (26.86M) | [{"date":"2019-12-31","value":-2938000000,"profit":false},{"date":"2020-12-31","value":-2874400000,"profit":false},{"date":"2021-12-31","value":-1830400000,"profit":false},{"date":"2022-12-31","value":-2314000000,"profit":false},{"date":"2023-12-31","value":-2686000000,"profit":false}] |
Pre-Tax Income | 81.99M | (91.18M) | 36.11M | 29.95M | 41.21M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-111.2,"profit":false},{"date":"2021-12-31","value":44.04,"profit":true},{"date":"2022-12-31","value":36.53,"profit":true},{"date":"2023-12-31","value":50.26,"profit":true}] |
Income Taxes | (12.29M) | 5.90M | 15.89M | 10.30M | 4.18M | [{"date":"2019-12-31","value":-77.34,"profit":false},{"date":"2020-12-31","value":37.1,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":64.79,"profit":true},{"date":"2023-12-31","value":26.34,"profit":true}] |
Income After Taxes | 94.28M | (97.07M) | 20.22M | 19.66M | 37.02M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-102.96,"profit":false},{"date":"2021-12-31","value":21.44,"profit":true},{"date":"2022-12-31","value":20.85,"profit":true},{"date":"2023-12-31","value":39.27,"profit":true}] |
Income From Continuous Operations | 94.28M | (97.07M) | 20.22M | 19.66M | 37.02M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-102.96,"profit":false},{"date":"2021-12-31","value":21.44,"profit":true},{"date":"2022-12-31","value":20.85,"profit":true},{"date":"2023-12-31","value":39.27,"profit":true}] |
Income From Discontinued Operations | 7.83M | (424.00K) | - | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-5.41,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 101.98M | (97.07M) | 19.73M | 19.45M | 36.67M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-95.19,"profit":false},{"date":"2021-12-31","value":19.34,"profit":true},{"date":"2022-12-31","value":19.07,"profit":true},{"date":"2023-12-31","value":35.96,"profit":true}] |
EPS (Diluted) | 1.78 | 0.79 | 0.71 | 0.58 | 0.81 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":44.38,"profit":true},{"date":"2021-12-31","value":39.89,"profit":true},{"date":"2022-12-31","value":32.58,"profit":true},{"date":"2023-12-31","value":45.51,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
CLB | |
---|---|
Cash Ratio | 0.23 |
Current Ratio | 2.48 |
Quick Ratio | 1.79 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CLB | |
---|---|
ROA (LTM) | 5.89% |
ROE (LTM) | 11.16% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CLB | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.57 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CLB | |
---|---|
Trailing PE | 33.33 |
Forward PE | 19.38 |
P/S (TTM) | 1.62 |
P/B | 3.41 |
Price/FCF | 78 |
EV/R | 1.97 |
EV/Ebitda | 13.87 |
PEG | 1.63 |
Core Laboratories NV (CLB) share price today is $18
Yes, Indians can buy shares of Core Laboratories NV (CLB) on Vested. To buy Core Laboratories NV from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Core Laboratories NV (CLB) via the Vested app. You can start investing in Core Laboratories NV (CLB) with a minimum investment of $1.
You can invest in shares of Core Laboratories NV (CLB) via Vested in three simple steps:
The 52-week high price of Core Laboratories NV (CLB) is $25.11. The 52-week low price of Core Laboratories NV (CLB) is $13.8.
The price-to-earnings (P/E) ratio of Core Laboratories NV (CLB) is 34.2778
The price-to-book (P/B) ratio of Core Laboratories NV (CLB) is 3.41
The dividend yield of Core Laboratories NV (CLB) is 0.22%
The market capitalization of Core Laboratories NV (CLB) is $845.10M
The stock symbol (or ticker) of Core Laboratories NV is CLB